- 米国企業
- ADIAL PHARMACEUTICALS, INC.
ADIAL PHARMACEUTICALS, INC.ADIL
時価総額
$171.7万
PER
| 2018年 12月31日 | 2019年 12月31日 | 2020年 12月31日 | 2021年 12月31日 | 2022年 12月31日 | |
| Research and development | 368,459 | 4 | 6 | 8 | 4 |
| General and administrative | 7 | 4 | 5 | 9 | 9 |
| Impairment expenses | - | - | - | 2 | - |
| Total Operating Expenses | 7 | 8 | 11 | 19 | 13 |
| Loss From Operations | -6,987,222 | -8,244,900 | -10,927,985 | -19,288,723 | -13,317,127 |
| Interest income | 7,392 | 95,234 | 32,495 | 6,539 | 63,209 |
| Change in fair value of contingent liability | - | - | - | -281,713 | 522,000 |
| Other income | - | - | - | 46,494 | - |
| Total other income (expense) | -4,644,156 | -346,529 | 34,995 | -228,680 | 585,209 |
| Loss Before Provision For Income Taxes | -11,631,378 | -8,591,429 | -10,892,990 | -19,517,403 | -12,731,918 |
| Income tax benefit | - | - | - | -94,077 | -502 |
| Net Loss | -11,631,378 | -8,591,429 | -10,892,990 | -19,423,326 | -12,731,416 |
| Net loss per share, basic and diluted (in Dollars per share) | - | - | - | - | -0.51 |